## Alpha Blockers in BPH and Hypertension: Dual-Benefit Considerations ### Clinical Context Alpha-1 blockers relieve BPH symptoms by relaxing smooth muscle in the prostate capsule and bladder neck (alpha-1A receptors). Non-selective blockers additionally lower blood pressure by relaxing vascular smooth muscle (alpha-1B receptors). ### Suitability for Dual Benefit | Drug | Selectivity | BPH Relief | BP Lowering | Dual Benefit? | Notes | |------|-------------|-----------|------------|---------------|-------| | **Doxazosin** | Non-selective | ✓ Yes | ✓ Yes | ✓ **YES** | First-line for BPH + HTN; once-daily dosing | | **Terazosin** | Non-selective | ✓ Yes | ✓ Yes | ✓ **YES** | Effective for both; twice-daily dosing | | **Tamsulosin** | Alpha-1A selective | ✓ Yes | ✗ Minimal | ✗ **NO** | Minimal vascular effects; not recommended for HTN | | **Prazosin** | Non-selective | ✓ Yes | ✓ Yes | ✓ **YES** | Effective for both; first-dose syncope limits use | ### Key Point: **High-Yield:** Tamsulosin's **alpha-1A selectivity** (10-fold) means it preferentially blocks prostate receptors while sparing vascular alpha-1B receptors. This selectivity is a **disadvantage** when hypertension control is desired, as tamsulosin produces minimal blood pressure reduction. ### Clinical Pearl: In a patient with both BPH and hypertension, **doxazosin** or **terazosin** are preferred because they provide dual benefit. Tamsulosin should be reserved for BPH-only patients or those with hypertension already controlled by other agents, as it will not contribute to BP management. ### Mnemonic: **"DTPD for Dual Therapy"** - **D**oxazosin → Dual benefit (BPH + BP) - **T**erazosin → Dual benefit (BPH + BP) - **P**razosin → Dual benefit (BPH + BP) - **D**amn **T**amsulosin → **T**argeted (prostate only, no BP benefit) [cite:KD Tripathi 8e Ch 10; Harrison 21e Ch 297]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.